Long-term dietary potential renal acid load during adolescence is prospectively associated with indices of nonalcoholic fatty liver disease in young women

Journal of Nutrition

Volumn 142, Issue 2, 2012, Pages 313-319

  Krupp, Danika ^a   Johner, Simone A ^a   Kalhoff, Hermann ^b   Buyken, Anette E ^a   Remer, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Pediatric Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADOLESCENCE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ASSESSMENT TOOL; DISEASE ASSOCIATION; FATTY LIVER INDEX; FEMALE; HEPATIC STEATOSIS INDEX; HUMAN; HUMAN EXPERIMENT; MALE; NONALCOHOLIC FATTY LIVER; NORMAL HUMAN; NUTRITIONAL PARAMETERS; POTENTIAL RENAL ACID LOAD; PROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE;

ACIDS; ADOLESCENT; ADULT; DIET; DIET SURVEYS; FATTY LIVER; FEMALE; FOOD ANALYSIS; FOOD HABITS; HUMANS; KIDNEY; MALE; SEX FACTORS; YOUNG ADULT;

EID: 84858174256     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.150540     Document Type: Article

References (49)

1. Stefan N, Kantartzis K, Haring HU. Causes and metabolic consequences of fatty liver. Endocr Rev. 2008;29:939-60.
2. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of nonalcoholic fatty liver disease. Dig Dis. 2010;28:155-61.
3. Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007;133:1814-20.
4. Caserta CA, Pendino GM, Amante A, Vacalebre C, Fiorillo MT, Surace P, Messineo A, Surace M, Alicante S, Cotichini R, et al. Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intimamedia thickness in an adolescent population in southern Italy. Am J Epidemiol. 2010;171:1195-202.
5. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13:1579-84.
6. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology. 2010;52:1156-61.
7. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
8. Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, KimW, Kim YJ, Yoon JH, Cho SH, Sung MW, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42:503-8.
9. Ichikawa T, Nakao K, Hamasaki K, Furukawa R, Tsuruta S, Ueda Y, Taura N, Shibata H, Fujimoto M, Toriyama K, et al. Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factorbinding protein 3 in development of non-alcoholic fatty liver disease. Hepatol Int. 2007;1:287-94.
10. Lonardo A, Loria P, Leonardi F, Ganazzi D, Carulli N. Growth hormone plasma levels in nonalcoholic fatty liver disease. Am J Gastroenterol. 2002;97:1071-2.
11. Vö lzke H, Nauck M, Rettig R, Dorr M, Higham C, Brabant G, Wallaschofski H. Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. Eur J Endocrinol. 2009;161:705-13.
12. Green J, Maor G. Effect of metabolic acidosis on the growth hormone/IGF-I endocrine axis in skeletal growth centers. Kidney Int. 2000;57:2258-67.
13. Brü ngger M, Hulter HN, Krapf R. Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans. Kidney Int. 1997;51:216-21.
14. Wiederkehr MR, Kalogiros J, Krapf R. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant. 2004;19:1190-7.
15. Remer T, Manz F. Estimation of the renal net acid excretion by adults consuming diets containing variable amounts of protein. Am J Clin Nutr. 1994;59:1356-61.
16. Kurtz I, Maher T, Hulter HN, Schambelan M, Sebastian A. Effect of diet on plasma acid-base composition in normal humans. Kidney Int. 1983;24:670-80.
17. Maurer M, Riesen W, Muser J, Hulter HN, Krapf R. Neutralization of Western diet inhibits bone resorption independently of K intake and reduces cortisol secretion in humans. Am J Physiol Renal Physiol. 2003;284:F32-40.
18. Kroke A, Manz F, Kersting M, Remer T, Sichert-Hellert W, Alexy U, Lentze MJ. The DONALD Study. History, current status and future perspectives. Eur J Nutr. 2004;43:45-54.
19. World Health Organization, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: WHO, International Diabetes Federation; 2006.
20. Sichert-Hellert W, Kersting M, Schoch G. Underreporting of energy intake in 1 to 18 year old German children and adolescents. Z Ernahrungswiss. 1998;37:242-51.
21. Chiavaroli V, Giannini C, D'Adamo E, de Giorgis T, Chiarelli F, Mohn A. Insulin resistance and oxidative stress in children born small and large for gestational age. Pediatrics. 2009;124:695-702.
22. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290-6.
23. Meas T, Deghmoun S, Alberti C, Carreira E, Armoogum P, Chevenne D, Levy-Marchal C. Independent effects of weight gain and fetal programming on metabolic complications in adults born small for gestational age. Diabetologia. 2010;53:907-13.
24. Sichert-Hellert W, Kersting M, Chada C, Schä fer K, Kroke A. German food composition database for dietary evaluations in children and adolescents. J Food Compost Anal. 2007;20:63-70.
25. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß H, Hesse V, von Hippe A, Jaeger U, Johnsen D, Korte W, et al. Perzentile für den Body-mass-index fü r das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben Monatsschr Kinderheilkd. 2001; 149:807-18.
26. Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, Bemben DA. Skinfold equations for estimation of body fatness in children and youth. Hum Biol. 1988;60:709-23.
27. Alexy U, Kersting M, Remer T. Potential renal acid load in the diet of children and adolescents: impact of food groups, age and time trends. Public Health Nutr. 2008;11:300-6.
28. Remer T, Dimitriou T, Manz F. Dietary potential renal acid load and renal net acid excretion in healthy, free-living children and adolescents. Am J Clin Nutr. 2003;77:1255-60.
29. Remer T, Shi L, Buyken AE, Maser-Gluth C, Hartmann MF, Wudy SA. Prepubertal adrenarchal androgens and animal protein intake independently and differentially influence pubertal timing. J Clin Endocrinol Metab. 2010;95:3002-9.
30. Yki-Järvinen H. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. Curr Opin Clin Nutr Metab Care. 2010;13:709-14.
31. Sullivan S. Implications of diet on nonalcoholic fatty liver disease. Curr Opin Gastroenterol. 2010;26:160-4.
32. McCarty MF. Acid-base balance may influence risk for insulin resistance syndrome by modulating cortisol output. Med Hypotheses. 2005;64:380-4.
33. Otsuki M, Kitamura T, Goya K, Saito H, Mukai M, Kasayama S, Shimomura I, Koga M. Association of urine acidification with visceral obesity and the metabolic syndrome. Endocr J. 2011;58:363-7.
34. Murakami K, Sasaki S, Takahashi Y, Uenishi K. Association between dietary acid-base load and cardiometabolic risk factors in young Japanese women. Br J Nutr. 2008;100:642-51.
35. Kleinknecht C, Maniar S, Zhou X, Motel V, Laouari D, Yvert JP, Dechaux M. Acidosis prevents growth hormone-induced growth in experimental uremia. Pediatr Nephrol. 1996;10:256-60.
36. Ordóñez FA, Santos F, Martinez V, Garcia E, Fernandez P, Rodriguez J, Fernandez M, Alvarez J, Ferrando S. Resistance to growth hormone and insulin-like growth factor-I in acidotic rats. Pediatr Nephrol. 2000;14:720-5.
37. Ceglia L, Harris SS, Abrams SA, Rasmussen HM, Dallal GE, Dawson-Hughes B. Potassium bicarbonate attenuates the urinary nitrogen excretion that accompanies an increase in dietary protein and may promote calcium absorption. J Clin Endocrinol Metab. 2009;94:645-53.
38. Fan Y, Menon RK, Cohen P, Hwang D, Clemens T, DiGirolamo DJ, Kopchick JJ, Le Roith D, Trucco M, Sperling MA. Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem. 2009;284:19937-44.
39. Bredella MA, Torriani M, Thomas BJ, Ghomi RH, Brick DJ, Gerweck AV, Miller KK. Peak growth hormone-releasing hormone-argininestimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J Clin Endocrinol Metab. 2009;94:3995-4002.
40. Vijayakumar A, Novosyadlyy R, Wu Y, Yakar S, LeRoith D. Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm IGF Res. 2010;20:1-7.
41. Gannon MC, Nuttall FQ. Effect of a high-protein diet on ghrelin, growth hormone, and insulin-like growth factor-I and binding proteins 1 and 3 in subjects with type 2 diabetes mellitus. Metabolism. 2011; 60:1300-11.
42. Mauras N, Bishop K, Welch S. Growth hormone action in puberty: effects by gender. Growth Horm IGF Res. 2007;17:463-71.
43. Soares DV, Conceicao FL, Brasil RR, Spina LD, Lobo PM, Silva EM, Buescu A, Vaisman M. Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: a gender difference. Growth Horm IGF Res. 2004;14:436-41.
44. Ghigo E, Aimaretti G, Maccario M, Fanciulli G, Arvat E, Minuto F, Giordano G, Delitala G, Camanni F. Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol. 1999;276:E1009-13.
45. Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, Hakkinen AM, Fredriksson J, Yki-Jarvinen H. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004;47:1360-9.
46. Graham RC, Burke A, Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J Pediatr Gastroenterol Nutr. 2009;49:442-9.
47. Oh HJ, Kim TH, Sohn YW, Kim YS, Oh YR, Cho EY, Shim SY, Shin SR, Han AL, Yoon SJ, et al. Association of serum alanine aminotransferase and gamma-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease. Korean J Hepatol. 2011;17:27-36.
48. Gastaldelli A, Kozakova M, Hojlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology. 2009;49:1537-44.
49. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol. 2010;10:56.